Finance

Lists
Why is 000739 down 8,07%?
Dive Deeper
000739:SHE
Apeloa Pharmaceutical Co Ltd
21,53 CN¥
-8,07%
(-1,89) 1D
19 հոկ, 11:04:33 GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 000739...
Open
23,02 CN¥
High
23,57 CN¥
Low
21,08 CN¥
Mkt. cap
27,13 մլրդ
Avg. vol.
16,57 մլն
Volume
23,56 մլն
Dividend
1,75%
Quarterly dividend
0,09 CN¥
Ex-dividend date
08 հոկ, 2026 թ.
P/E ratio
29,22
52-wk high
28,50 CN¥
52-wk low
14,89 CN¥
EPS
0,74 CN¥
Shares outstanding
1,16 մլրդ
No. of employees
7 հզր
Open
23,02 CN¥
High
23,57 CN¥
Low
21,08 CN¥
Mkt. cap
27,13 մլրդ
Avg. vol.
16,57 մլն
Volume
23,56 մլն
Dividend
1,75%
Quarterly dividend
0,09 CN¥
Ex-dividend date
08 հոկ, 2026 թ.
P/E ratio
29,22
52-wk high
28,50 CN¥
52-wk low
14,89 CN¥
EPS
0,74 CN¥
Shares outstanding
1,16 մլրդ
No. of employees
7 հզր
News stories
From web sources and news partners
Profile
Apeloa Pharmaceutical Co., Ltd., known as Apeloa, is a Chinese pharmaceutical manufacturer under Hengdian Group. The company is headquartered in Hengdian, Dongyang, Zhejiang, China. It was founded in 1989 and has been listed on the Shenzhen Stock Exchange since 9 May 1997. Apeloa provides contract development and manufacturing services and manufactures APIs and finished dosage forms; products span cardiovascular, anti-infective, psychiatric and oncology areas. Apeloa has 7400 employees, 8 manufacturing sites and 3 R&D centers in Boston, Shanghai and Hengdian, covering flow chemistry, synthetic biology and biocatalysis, and peptide development. It has invested over USD20 million in flow chemistry over the past ten years in an effort to advance sustainable pharmaceutical manufacturing. In Boston, its 17,000-square-foot facility does R&D related to chemistry needs in drug development, including preclinical chemistry, scale-up production and new drug development. Apeloa Pharmaceutical has successfully passed 20 U.S. FDA inspections since 2006. Wikipedia
About Apeloa Pharmaceutical Co Ltd
CEO-
Employees6,79 հզր
Founded1989
Headquarters-
Sector-
Websiteapeloa.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
2,32 մլրդ
2,02 մլրդ
2,45 մլրդ
2,38 մլրդ
Cost of goods sold
1,75 մլրդ
1,48 մլրդ
1,73 մլրդ
1,69 մլրդ
Cost of revenue
1,75 մլրդ
1,48 մլրդ
1,73 մլրդ
1,69 մլրդ
Research and development expenses
140,81 մլն
146,16 մլն
134,93 մլն
143,88 մլն
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
231,94 մլն
275,50 մլն
219,12 մլն
203,71 մլն
Operating expense
330,71 մլն
483,17 մլն
380,47 մլն
371,82 մլն
Total operating expenses
2,08 մլրդ
1,96 մլրդ
2,11 մլրդ
2,06 մլրդ
Operating income
239,75 մլն
60,19 մլն
336,71 մլն
311,76 մլն
Other non operating income
-7,84 մլն
7,46 մլն
-33,21 մլն
31,72 մլն
EBT including unusual items
180,55 մլն
227,06 մլն
297,81 մլն
323,80 մլն
EBT excluding unusual items
242,07 մլն
80,73 մլն
306,22 մլն
288,49 մլն
Income tax expense
43,43 մլն
36,57 մլն
48,54 մլն
50,52 մլն
Effective tax rate
24,06%
16,10%
16,30%
15,60%
Other operating expenses
-29,24 մլն
53,54 մլն
13,18 մլն
11,46 մլն
Net income
137,22 մլն
190,41 մլն
249,02 մլն
273,35 մլն
Net profit margin
5,92%
9,43%
10,17%
11,51%
Earnings per share
-
-
-
-
Interest and investment income
22,93 մլն
46,65 մլն
10,66 մլն
17,28 մլն
Interest expense
-5,29 մլն
-8,06 մլն
-7,95 մլն
-8,10 մլն
Net interest expenses
17,64 մլն
38,60 մլն
2,71 մլն
9,18 մլն
Depreciation and amortization charges
-
-
-
-
EBITDA
380,74 մլն
225,73 մլն
502,26 մլն
478,57 մլն
Gain or loss from assets sale
1,16 մլն
-9,03 մլն
-
-136,29 հզր
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google Apps